Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 31:16:100459.
doi: 10.1016/j.resplu.2023.100459. eCollection 2023 Dec.

Vasopressin versus epinephrine during cardiopulmonary resuscitation of asphyxiated newborns: A study protocol for a prospective, cluster, open label, single-center, randomized controlled phase 2 trial - The VERSE-Trial

M Ramsie  1   2 , P-Y Cheung  1   2 , B Law  1   2 , G M Schmölzer  1   2
Affiliations

Vasopressin versus epinephrine during cardiopulmonary resuscitation of asphyxiated newborns: A study protocol for a prospective, cluster, open label, single-center, randomized controlled phase 2 trial - The VERSE-Trial

M Ramsie et al. Resusc Plus. .

Abstract

Introduction: Current neonatal resuscitation guidelines recommend the use of epinephrine during neonatal cardiopulmonary resuscitation (CPR). However, newborns receiving epinephrine continue to have high rates of mortality and neurodevelopmental disability. The infrequent need for neonatal CPR, coupled with an inability to consistently anticipate which newborn infants are at risk of requiring CPR, explains the lack of high-quality evidence (i.e., large randomized clinical trials) to better guide healthcare providers in their resuscitative effort. Therefore, we need neonatal data to determine the optimal vasopressor therapy during neonatal CPR. The current pilot trial will examine the efficacy of vasopressin versus epinephrine during CPR of asphyxiated newborn infants.

Methods and analysis: The trial will be a prospective, cluster, open label, single-center, randomized controlled trial on two alternative cardiovascular supportive medications. This study will assess the primary outcome of time to return of spontaneous circulation (ROSC) in newborns requiring CPR in the delivery room who were treated with either vasopressin (intervention) or epinephrine (control). Secondary outcomes such as infant mortality and other clinical outcome measures will also be collected. An estimated 20 newborns will be recruited, and comparisons will be made between asphyxiated infants treated with either drugs.

Ethics and dissemination: This study has been approved by the Research Ethics Board at the University of Alberta (June 16, 2023). Study findings will be published in peer-reviewed journals, presented at conferences, and communicated to relevant participants and stakeholders.Trial registration: ClinicalTrial.gov Identifier: NCT05738148. Registered February 21, 2023.

Keywords: Adrenaline; Asphyxia; CHEST compressions; Epinephrine; Infants; Neonatal resuscitation; Newborn; Vasopressin.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Trial flow chart.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Wyckoff M.H., Wyllie J.P., Aziz K., de Almeida M.F., Fabres J., Fawke J., et al. Neonatal life support: 2020 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations. Circulation. 2020;142:329–337. doi: 10.1161/cir.0000000000000895. - DOI - PubMed
    1. Aziz K., Lee H.C., Escobedo M.B., Hoover A.V., Kamath-Rayne B.D., Kapadia V.S., et al. Part 5: Neonatal Resuscitation: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142:1–27. doi: 10.1161/cir.0000000000000902. - DOI - PubMed
    1. Pinto M., Solevåg A., OʼReilly M., Aziz K., Cheung P.-Y., Schmölzer G.M. Evidence on adrenaline use in resuscitation and its relevance to newborn infants: A non-systematic review. Neonatology. 2017;111:37–44. doi: 10.1159/000447960. - DOI - PubMed
    1. Kapadia V.S., Wyckoff M.H. Epinephrine use during newborn resuscitation. Front Pediatr. 2017;5:97. doi: 10.3389/fped.2017.00097. - DOI - PMC - PubMed
    1. Vali P., Sankaran D., Rawat M., Berkelhamer S., Lakshminrusimha S. Epinephrine in neonatal resuscitation. Children. 2019;6:51–115. doi: 10.3390/children6040051. - DOI - PMC - PubMed

Associated data